(+)-catechin multiple interactions ISO RGD:1345907 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of FZD5 mRNA CTD PMID:24763279 1,2-dimethylhydrazine decreases expression ISO RGD:1551974 6480464 1, 2-Dimethylhydrazine results in decreased expression of FZD5 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1345907 6480464 Estradiol results in increased expression of FZD5 mRNA CTD PMID:23019147 17beta-estradiol multiple interactions ISO RGD:1345907 6480464 [Estradiol co-treated with Progesterone] results in increased expression of FZD5 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of FZD5 mRNA CTD PMID:20660070 , PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1345907 6480464 Dihydrotestosterone results in increased expression of FZD5 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551974 6480464 Tetrachlorodibenzodioxin results in decreased expression of FZD5 mRNA CTD PMID:19933214 , PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FZD5 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551974 6480464 Tetrachlorodibenzodioxin affects the expression of FZD5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FZD5 mRNA CTD PMID:22298810 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1551974 6480464 tetrabromobisphenol A results in increased expression of FZD5 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1551974 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of FZD5 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1345907 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD5 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1551974 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FZD5 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1551974 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of FZD5 exon CTD PMID:33297965 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FZD5 mRNA CTD PMID:31881176 all-trans-retinoic acid decreases expression ISO RGD:1345907 6480464 Tretinoin results in decreased expression of FZD5 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:1345907 6480464 Tretinoin results in increased expression of FZD5 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FZD5 mRNA CTD PMID:16483693 arsenous acid increases expression ISO RGD:1345907 6480464 Arsenic Trioxide results in increased expression of FZD5 mRNA CTD PMID:22521957 atrazine increases expression ISO RGD:1345907 6480464 Atrazine results in increased expression of FZD5 mRNA CTD PMID:22378314 belinostat decreases expression ISO RGD:1345907 6480464 belinostat results in decreased expression of FZD5 mRNA CTD PMID:26272509 benzo[a]pyrene increases expression ISO RGD:1345907 6480464 Benzo(a)pyrene results in increased expression of FZD5 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:1345907 6480464 Benzo(a)pyrene affects the methylation of FZD5 3' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345907 6480464 7 more ... CTD PMID:20018196 bisphenol A decreases expression ISO RGD:1345907 6480464 bisphenol A results in decreased expression of FZD5 mRNA CTD PMID:16029874 bisphenol A increases expression ISO RGD:1551974 6480464 bisphenol A results in increased expression of FZD5 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1345907 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD5 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FZD5 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol F increases expression ISO RGD:1551974 6480464 bisphenol F results in increased expression of FZD5 mRNA CTD PMID:30951980 butanal decreases expression ISO RGD:1345907 6480464 butyraldehyde results in decreased expression of FZD5 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:1551974 6480464 Cadmium Chloride results in increased expression of FZD5 mRNA CTD PMID:20478370 caffeine decreases phosphorylation ISO RGD:1345907 6480464 Caffeine results in decreased phosphorylation of FZD5 protein CTD PMID:35688186 calcitriol increases expression ISO RGD:1345907 6480464 Calcitriol results in increased expression of FZD5 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1345907 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FZD5 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1345907 6480464 Carbamazepine affects the expression of FZD5 mRNA CTD PMID:24752500 , PMID:25979313 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of FZD5 mRNA CTD PMID:18502319 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of FZD5 mRNA CTD PMID:27905518 chlorpyrifos multiple interactions EXP 6480464 [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of FZD5 mRNA CTD PMID:27905518 chlorpyrifos decreases expression ISO RGD:1551974 6480464 Chlorpyrifos results in decreased expression of FZD5 mRNA CTD PMID:27905518 cobalt dichloride decreases expression ISO RGD:1345907 6480464 cobaltous chloride results in decreased expression of FZD5 mRNA CTD PMID:19376846 cyclosporin A decreases expression ISO RGD:1345907 6480464 Cyclosporine results in decreased expression of FZD5 mRNA CTD PMID:20106945 , PMID:25562108 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of FZD5 mRNA CTD PMID:23640034 decabromodiphenyl ether increases expression ISO RGD:1345907 6480464 decabromobiphenyl ether results in increased expression of FZD5 mRNA CTD PMID:31326446 dexamethasone increases expression ISO RGD:1551974 6480464 Dexamethasone results in increased expression of FZD5 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1345907 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD5 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:1551974 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FZD5 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:1345907 6480464 Arsenic Trioxide results in increased expression of FZD5 mRNA CTD PMID:22521957 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of FZD5 mRNA CTD PMID:19130878 diclofenac affects expression ISO RGD:1345907 6480464 Diclofenac affects the expression of FZD5 mRNA CTD PMID:24752500 diethylstilbestrol increases expression ISO RGD:1345907 6480464 Diethylstilbestrol results in increased expression of FZD5 mRNA CTD PMID:19371625 dorsomorphin multiple interactions ISO RGD:1345907 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1345907 6480464 Doxorubicin results in decreased expression of FZD5 mRNA CTD PMID:29803840 entinostat decreases expression ISO RGD:1345907 6480464 entinostat results in decreased expression of FZD5 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1345907 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FZD5 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1551974 6480464 epoxiconazole results in increased expression of FZD5 mRNA CTD PMID:35436446 etacrynic acid increases expression ISO RGD:1345907 6480464 Ethacrynic Acid results in increased expression of FZD5 mRNA CTD PMID:20011538 Ethylenethiourea multiple interactions EXP 6480464 [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of FZD5 mRNA CTD PMID:27905518 Ethylenethiourea decreases expression ISO RGD:1551974 6480464 Ethylenethiourea results in decreased expression of FZD5 mRNA CTD PMID:27905518 etoposide decreases expression ISO RGD:1551974 6480464 Etoposide results in decreased expression of FZD5 mRNA CTD PMID:25270620 folic acid multiple interactions ISO RGD:1551974 6480464 [Folic Acid co-treated with sodium arsenite] results in increased methylation of FZD5 mRNA CTD PMID:22959928 folic acid decreases expression ISO RGD:1551974 6480464 Folic Acid results in decreased expression of FZD5 mRNA CTD PMID:25629700 genistein increases expression ISO RGD:1345907 6480464 Genistein results in increased expression of FZD5 mRNA CTD PMID:23019147 hydrogen peroxide affects expression ISO RGD:1345907 6480464 Hydrogen Peroxide affects the expression of FZD5 mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:1345907 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD5 mRNA CTD PMID:28628672 isotretinoin decreases expression ISO RGD:1345907 6480464 Isotretinoin results in decreased expression of FZD5 mRNA CTD PMID:20436886 leflunomide increases expression ISO RGD:1345907 6480464 leflunomide results in increased expression of FZD5 mRNA CTD PMID:28988120 methyl methanesulfonate increases expression ISO RGD:1345907 6480464 Methyl Methanesulfonate results in increased expression of FZD5 mRNA CTD PMID:23649840 nickel atom increases expression EXP 6480464 Nickel results in increased expression of FZD5 mRNA CTD PMID:19130878 niclosamide increases expression ISO RGD:1345907 6480464 Niclosamide results in increased expression of FZD5 mRNA CTD PMID:22576131 panobinostat decreases expression ISO RGD:1345907 6480464 panobinostat results in decreased expression of FZD5 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1345907 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FZD5 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1345907 6480464 Acetaminophen results in decreased expression of FZD5 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FZD5 mRNA CTD PMID:33387578 phenylmercury acetate decreases expression ISO RGD:1345907 6480464 Phenylmercuric Acetate results in decreased expression of FZD5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1345907 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FZD5 mRNA CTD PMID:27188386 potassium dichromate decreases expression ISO RGD:1551974 6480464 Potassium Dichromate results in decreased expression of FZD5 mRNA CTD PMID:23608068 progesterone multiple interactions ISO RGD:1345907 6480464 [Estradiol co-treated with Progesterone] results in increased expression of FZD5 mRNA CTD PMID:20660070 SB 431542 multiple interactions ISO RGD:1345907 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1345907 6480464 Silicon Dioxide analog results in decreased expression of FZD5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1551974 6480464 Silicon Dioxide results in increased expression of FZD5 mRNA CTD PMID:19073995 silver atom decreases expression ISO RGD:1551974 6480464 Silver results in decreased expression of FZD5 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1551974 6480464 Silver results in decreased expression of FZD5 mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO RGD:1551974 6480464 [Folic Acid co-treated with sodium arsenite] results in increased methylation of FZD5 mRNA CTD PMID:22959928 testosterone increases expression ISO RGD:1345907 6480464 Testosterone results in increased expression of FZD5 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1345907 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FZD5 mRNA CTD PMID:21592394 Tetrachlorobisphenol A increases expression ISO RGD:1345907 6480464 tetrachlorodian results in increased expression of FZD5 mRNA CTD PMID:31326446 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FZD5 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1551974 6480464 titanium dioxide results in increased expression of FZD5 mRNA CTD PMID:29128614 , PMID:29264374 titanium dioxide multiple interactions ISO RGD:1551974 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FZD5 mRNA CTD PMID:29950665 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FZD5 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1345907 6480464 trichostatin A results in decreased expression of FZD5 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1345907 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FZD5 mRNA CTD PMID:27188386 urethane decreases expression ISO RGD:1345907 6480464 Urethane results in decreased expression of FZD5 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1345907 6480464 Valproic Acid results in increased expression of FZD5 mRNA CTD PMID:23527032 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of FZD5 mRNA CTD PMID:35594946 valproic acid multiple interactions ISO RGD:1345907 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FZD5 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1345907 6480464 Valproic Acid results in decreased expression of FZD5 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1345907 6480464 Valproic Acid affects the expression of FZD5 mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1345907 6480464 Valproic Acid results in increased methylation of FZD5 gene CTD PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of FZD5 mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:1345907 6480464 vorinostat results in decreased expression of FZD5 mRNA CTD PMID:26272509 zoledronic acid increases expression ISO RGD:1345907 6480464 zoledronic acid results in increased expression of FZD5 mRNA CTD PMID:24714768